The purpose of this study was to identify the anatomical variants (AVs) in the intracranial arterial circulation of patients who underwent neuro-interventional procedures (NIPs) and to describe their relationship with intracranial aneurysms (IA). We performed a cross-sectional analysis of angiographic images from patients who underwent NIP at the Interventional Neuroradiology Department of the National Institute of Neurology and Neurosurgery in México between July 1, 2020, and January 1, 2022. After reviewing images from 150 NIPs, we found 144 AVs., yielding a prevalence of 81%. Of these, 49 AVs (34%) were located in the anterior circulation (AC) and 95 (66%) in the posterior circulation (PC); 23 NIPs (16%) showed AVs in both the AC and PC. The most frequent AVs were the fetal pattern of the posterior cerebral artery (19%) and hypoplasia of the A1 segment (12%). AVs were significantly more common in patients with neurovascular disorders than those without (80% vs 49%, = .003) and in patients with IA compared to those without (68% vs 47%, = .048). In the studied population, AVs were predominantly located in the PC and are significantly more frequent in patients with neurovascular disorders, particularly those with IA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11803601PMC
http://dx.doi.org/10.1177/19714009251313516DOI Listing

Publication Analysis

Top Keywords

intracranial aneurysms
8
patients underwent
8
patients neurovascular
8
neurovascular disorders
8
avs
7
patients
5
anatomical variations
4
intracranial
4
variations intracranial
4
intracranial arteries
4

Similar Publications

Background: While existing research has established a link between dietary habits and the incidence of intracranial aneurysms, the application of Mendelian randomization to explore this association remains largely uncharted.

Methods: In our study, we analyzed a wide array of dietary factors using data from the IEU Open GWAS project, which included meat varieties, vegetarian foods, cereal and the frequency of alcohol intake. We included pooled intracranial aneurysm GWAS data from a comprehensive dataset of 7,495 cases.

View Article and Find Full Text PDF

Background: Endovascular treatment (EVT) has been recommended as a superior modality for the treatment of intracranial aneurysm. However, there still exists a worse percentage of poor functional outcome in patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH) undergoing EVT. Therefore, it is urgently needed to investigate the risk factors and develop a critical decision model in the subtype of such patients.

View Article and Find Full Text PDF

Introduction: Flow diverters are specialized stents used to treat intracranial aneurysms. Bioresorbable flow diverters (BRFDs) have been proposed as the next-generation of flow diverter technology. BRFDs aim to occlude and heal the aneurysm before safely dissolving into the body, mitigating complications associated with the permanent presence of conventional flow diverters.

View Article and Find Full Text PDF

Background: Decompressive craniectomy (DC) is a last-tier treatment for managing refractory intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage (aSAH), though concerns persist about whether it primarily prolongs survival in a state of severe disability. This study investigated patient characteristics, surgical indications, complications, and outcomes following DC in aSAH.

Methods: In this Swedish, retrospective multi-center study, 123 aSAH patients treated with DC between 2008-2022 were included.

View Article and Find Full Text PDF

Despite successful management of pulmonary complication with fluid restriction protocol in aneurysmal subarachnoid hemorrhage (aSAH) patients treated with clazosentan, management of symptoms related to mucosal edema, such as diarrhea, stuffy nose, and difficulty in breathing, remains challenging. Hence, we investigated the effect of Goreisan shown to be effective in the treatment of symptoms related with mucosal edema in aSAH patients treated with clazosentan. Patients with aSAH who received clazosentan for vasospasm after aneurysm obliteration were prospectively enrolled in the study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!